Rep. Mariannette Miller-Meeks

Maddy summaryThis bill extends current Medicare payment rates for durable medical equipment (like wheelchairs and oxygen) in non-rural areas through December 2025. It delays implementing a new payment rule for all areas until January 2026. The law directly affects Medicare beneficiaries needing equipment and the suppliers who provide it by maintaining existing reimbursement rates for an additional year. This avoids immediate payment reductions for non-rural areas while postponing the full transition to new rates.

Maddy summaryThis bill creates a process for establishing Medicare payment rates for pediatric-specific medical devices. It requires the Medicare program (via the Secretary of Health and Human Services) to set national payment rates (called "relative value units") for qualifying pediatric technologies upon manufacturer request, starting in 2026. A "qualifying pediatric technology" is defined as a covered medical device that is FDA-approved/cleared, has a temporary HCPCS code, and is either predominantly used for pediatric procedures or specifically designed for children. Manufacturers must submit detailed data with their requests, and the timeline for setting rates depends on when the request is received (by May 1 for same-year implementation). The bill does not mandate coverage but ensures payment mechanisms exist for these devices once approved.

Maddy summaryThis bill amends the Clean Air Act to update the definition of fossil fuel, explicitly including "fuel for ocean-going vessels" alongside home heating oil and jet fuel. It directly affects the shipping industry by requiring the Environmental Protection Agency (EPA) to issue regulations within one year of enactment to implement this updated definition. The key mechanism is changing the statutory definition to ensure ocean vessel fuels are covered under existing fossil fuel regulations, potentially influencing future clean fuel standards for ships. The EPA must also submit a report to Congress on implementation within one year of finalizing these regulations.

Maddy summaryThe SPEED for BEAD Act (HR 1870) amends the federal broadband deployment program (BEAD) to accelerate network expansion. It defines "gigabit-level broadband" as 1,000 Mbps download speeds, requires unused funds to be returned to the Treasury instead of reallocated, and allows states to remove high-cost locations from project areas. The bill prohibits grant conditions related to labor practices (e.g., union requirements), diversity initiatives, climate policies, or network management rules, while ensuring all broadband technologies meeting speed standards are eligible. It also explicitly bans government regulation of broadband pricing, directly affecting states administering BEAD funds and the internet providers they fund.

Maddy summaryHR 1883, the Disclosing Foreign Influence in Lobbying Act, requires lobbying groups to disclose foreign governments or political parties that direct, plan, or control their lobbying activities. Specifically, it amends the Lobbying Disclosure Act of 1995 to mandate that registrants list the name and address of any foreign government (including local units like cities or regions) or foreign political party influencing their lobbying, beyond just the client they represent. This change clarifies that foreign entities directing lobbying efforts - not merely those being lobbied - must be disclosed. The bill directly affects lobbying organizations and firms registered under federal lobbying rules.

Maddy summaryThis bill adds a new tax provision (Section 139J) to the Internal Revenue Code, excluding interest income from certain rural and agricultural loans from taxable income for qualifying lenders. It directly affects banks, insurance companies, and farm credit entities that provide loans secured by rural or agricultural property (including qualifying single-family homes in rural areas), while excluding loans to foreign adversary entities (like those linked to China, Russia, or Iran). The law requires lenders to report on how this tax exclusion impacts loan interest rates, with a Treasury report due to Congress within five years. The policy change aims to reduce lenders' tax burden on these specific loans, potentially lowering costs for borrowers in rural communities.

Maddy summaryHR 1787 authorizes the U.S. Mint to produce commemorative coins honoring baseball legend Roberto Clemente, including $5 gold, $1 silver, and half-dollar coins, with specific specifications for weight, size, and metal content. The bill requires the coins to feature Clemente's image and commemorative inscriptions, and mandates a surcharge ($35 for gold, $10 for silver, $5 for half-dollar) paid to the Roberto Clemente Foundation for its educational, youth sports, and disaster relief programs. All coins must be minted in 2027, sold at face value plus surcharge and production costs, and will be legal tender. The bill focuses solely on the coin program, not broader policy changes.

Maddy summaryThe PLUS for Veterans Act of 2025 regulates how agents and attorneys can represent veterans in claims for benefits with the Department of Veterans Affairs. It establishes new requirements for these representatives, including application processes, conditional recognition periods while verification occurs, and caps on fees (limiting them to $12,500 or 5 times the monthly benefit increase). The bill reinstates penalties for unauthorized fee charging, including fines up to $50,000 and bars from representation for repeat violations. This legislation directly affects veterans seeking benefits, their representatives, and the Department of Veterans Affairs in handling claims. The bill also preempts state laws that conflict with these new federal regulations.

Maddy summaryThis bill extends the exclusivity period for certain advanced drugs from 7 to 11 years. It defines "advanced drug product" as a drug using genetically targeted technology to modulate gene function (e.g., suppress or activate genes). This change directly affects pharmaceutical companies developing these specific advanced therapies by granting them longer market exclusivity. The policy change modifies the Social Security Act to provide extended protection for these innovative drugs, allowing companies more time to recoup research and development costs.

Maddy summaryHRES 166 is a non-binding House resolution expressing U.S. support for the Iranian people's desire for a democratic, secular, and nonnuclear republic. It condemns the Iranian regime's terrorism, regional proxy wars, internal suppression of ethnic and religious minorities, and human rights abuses - including executions and repression of women-led protests. The resolution calls for holding the regime accountable through sanctions, supports the Ten-Point Plan for Iran’s democratic transition, and urges protection for Iranian political refugees in Albania. It does not create new laws but affirms U.S. policy alignment with Iranian protesters' demands.